Sun Pharmaceutical Industries Limited (SUNPHARMA.BO)
INR 1676.35
(1.25%)
INR 1676.35
(1.25%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 98.68 Billion INR | -6.13% |
| 2022 | 105.13 Billion INR | 16.85% |
| 2021 | 89.96 Billion INR | -0.0% |
| 2020 | 89.97 Billion INR | 14.25% |
| 2019 | 78.74 Billion INR | -0.14% |
| 2018 | 78.85 Billion INR | 14.61% |
| 2017 | 68.8 Billion INR | 0.7% |
| 2016 | 68.32 Billion INR | 6.39% |
| 2015 | 64.22 Billion INR | 13.33% |
| 2014 | 56.66 Billion INR | 81.46% |
| 2013 | 31.23 Billion INR | 21.15% |
| 2012 | 25.77 Billion INR | 23.52% |
| 2011 | 20.86 Billion INR | 40.11% |
| 2010 | 14.89 Billion INR | 38.7% |
| 2009 | 10.73 Billion INR | 10.06% |
| 2008 | 9.75 Billion INR | 26.26% |
| 2007 | 7.72 Billion INR | 16.3% |
| 2006 | 6.64 Billion INR | 29.85% |
| 2005 | 5.11 Billion INR | 61.28% |
| 2004 | 3.17 Billion INR | 24.81% |
| 2003 | 2.54 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 99.35 Billion INR | 0.0% |
| 2023 Q2 | 99.56 Billion INR | 0.0% |
| 2023 Q4 | 98.68 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 98.68 Billion INR | -6.13% |
| 2023 Q1 | - INR | -100.0% |
| 2022 FY | 105.13 Billion INR | 16.85% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 98.74 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 105.13 Billion INR | 0.0% |
| 2021 Q4 | 89.96 Billion INR | 0.0% |
| 2021 FY | 89.96 Billion INR | -0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 87.02 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 89.97 Billion INR | 14.25% |
| 2020 Q4 | 89.97 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 86.25 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 78.74 Billion INR | -0.14% |
| 2019 Q4 | 78.74 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 77.4 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 78.85 Billion INR | 14.61% |
| 2018 Q4 | 78.85 Billion INR | 0.0% |
| 2018 Q2 | 73.66 Billion INR | 0.0% |
| 2017 FY | 68.8 Billion INR | 0.7% |
| 2017 Q4 | 68.8 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 67.8 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q4 | 68.32 Billion INR | 0.0% |
| 2016 FY | 68.32 Billion INR | 6.39% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 63.52 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 62.7 Billion INR | 0.0% |
| 2015 Q4 | 64.22 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 64.22 Billion INR | 13.33% |
| 2014 Q4 | 56.66 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 33.41 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 56.66 Billion INR | 81.46% |
| 2013 FY | 31.23 Billion INR | 21.15% |
| 2013 Q4 | 31.23 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 30.08 Billion INR | 0.0% |
| 2012 FY | 25.77 Billion INR | 23.52% |
| 2012 Q4 | 25.77 Billion INR | 0.0% |
| 2012 Q2 | 24.53 Billion INR | 0.0% |
| 2011 Q4 | 20.86 Billion INR | 0.0% |
| 2011 FY | 20.86 Billion INR | 40.11% |
| 2010 FY | 14.89 Billion INR | 38.7% |
| 2009 FY | 10.73 Billion INR | 10.06% |
| 2008 FY | 9.75 Billion INR | 26.26% |
| 2007 FY | 7.72 Billion INR | 16.3% |
| 2006 FY | 6.64 Billion INR | 29.85% |
| 2005 FY | 5.11 Billion INR | 61.28% |
| 2004 FY | 3.17 Billion INR | 24.81% |
| 2003 FY | 2.54 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bal Pharma Limited | 878.11 Million INR | -11138.051% |
| Achyut Healthcare Limited | 568 Thousand INR | -17373650.0% |
| Alkem Laboratories Limited | 26.61 Billion INR | -270.824% |
| Divi's Laboratories Limited | 31.84 Billion INR | -209.934% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -292.682% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -1380.412% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -100633.841% |
| Mankind Pharma Limited | 15.53 Billion INR | -535.245% |
| Medicamen Biotech Limited | 593.75 Million INR | -16520.222% |
| Medico Remedies Limited | 163.37 Million INR | -60303.802% |
| Megasoft Limited | - INR | -Infinity% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -8944.35% |
| Piramal Pharma Limited | 21.75 Billion INR | -353.531% |
| Sequent Scientific Limited | 3.46 Billion INR | -2750.196% |
| Sigachi Industries Limited | 707.2 Million INR | -13853.892% |
| Ajanta Pharma Limited | 8.28 Billion INR | -1091.305% |
| Brooks Laboratories Limited | 96.1 Million INR | -102579.173% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -1435.061% |
| Themis Medicare Limited | 705.74 Million INR | -13882.838% |
| Unichem Laboratories Limited | 7.04 Billion INR | -1300.401% |
| Hester Biosciences Limited | 755.81 Million INR | -12956.575% |
| Venus Remedies Limited | 1.21 Billion INR | -8009.368% |
| Indoco Remedies Limited | 3.53 Billion INR | -2695.074% |
| Ind-Swift Limited | 640.91 Million INR | -15297.19% |
| Aarti Drugs Limited | 4.85 Billion INR | -1930.972% |
| Alpa Laboratories Limited | 136.65 Million INR | -72114.221% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -4230.439% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | -55.279% |
| Granules India Limited | 13 Billion INR | -658.781% |
| Gufic Biosciences Limited | 2 Billion INR | -4822.28% |
| Hikal Limited | 3.03 Billion INR | -3149.141% |
| RPG Life Sciences Limited | 1.01 Billion INR | -9670.584% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -4168.371% |
| Windlas Biotech Limited | 621.89 Million INR | -15768.224% |
| ZIM Laboratories Limited | 812.62 Million INR | -12043.66% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -94263.866% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -2222.825% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -665.221% |
| Aurobindo Pharma Limited | 98.08 Billion INR | -0.612% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -6751.162% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -386937.299% |
| Ipca Laboratories Limited | 24.71 Billion INR | -299.314% |
| Lasa Supergenerics Limited | 190.43 Million INR | -51720.001% |
| Laurus Labs Limited | 18.45 Billion INR | -434.748% |
| NATCO Pharma Limited | 7 Billion INR | -1308.749% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -1291.563% |
| Shilpa Medicare Limited | 3.44 Billion INR | -2760.97% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -2643.478% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -333.01% |
| Wanbury Limited | 360.23 Million INR | -27294.263% |
| Wockhardt Limited | 6.4 Billion INR | -1441.92% |
| Strides Pharma Science Limited | 11.26 Billion INR | -776.216% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -8231.376% |
| Suven Life Sciences Limited | 7.08 Million INR | -1392742.625% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -34040.78% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -500.429% |
| Eris Lifesciences Limited | 1.89 Billion INR | -5120.434% |
| Lupin Limited | 49.53 Billion INR | -99.202% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -46710.189% |
| Valiant Laboratories Limited | 100.15 Million INR | -98431.162% |
| Zydus Lifesciences Limited | 34.41 Billion INR | -186.711% |
| FDC Limited | 3.88 Billion INR | -2437.562% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -1863.8% |
| Novartis India Limited | 448.6 Million INR | -21897.971% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -65701.76% |
| Neuland Laboratories Limited | 3.5 Billion INR | -2716.117% |
| Morepen Laboratories Limited | 2.48 Billion INR | -3869.638% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -247349.599% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -7881.483% |